Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"Se Young Jang"

Article category

Keywords

Publication year

"Se Young Jang"

Original Articles

COVID-19

Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park
Clin Mol Hepatol 2020;26(4):562-576.
Published online October 1, 2020
DOI: https://doi.org/10.3350/cmh.2020.0126
Background/Aims
Although coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, the implication of pre-existing liver disease on the outcome of COVID-19 remains unresolved.

Methods
A total of 1,005 patients who were admitted to five tertiary hospitals in South Korea with laboratory-confirmed COVID-19 were included in this study. Clinical outcomes in COVID-19 patients with coexisting liver disease as well as the predictors of disease severity and mortality of COVID-19 were assessed.

Results
Of the 47 patients (4.7%) who had liver-related comorbidities, 14 patients (1.4%) had liver cirrhosis. Liver cirrhosis was more common in COVID-19 patients with severe pneumonia than in those with non-severe pneumonia (4.5% vs. 0.9%, P=0.006). Compared to patients without liver cirrhosis, a higher proportion of patients with liver cirrhosis required oxygen therapy; were admitted to the intensive care unit; had septic shock, acute respiratory distress syndrome, or acute kidney injury; and died (P<0.05). The overall survival rate was significantly lower in patients with liver cirrhosis than in those without liver cirrhosis (log-rank test, P=0.003). Along with old age and diabetes, the presence of liver cirrhosis was found to be an independent predictor of severe disease (odds ratio, 4.52; 95% confidence interval [CI], 1.20–17.02;P=0.026) and death (hazard ratio, 2.86; 95% CI, 1.04–9.30; P=0.042) in COVID-19 patients.

Conclusions
This study suggests liver cirrhosis is a significant risk factor for COVID-19. Stronger personal protection and more intensive treatment for COVID-19 are recommended in these patients.

Citations

Citations to this article as recorded by  Crossref logo
  • Assessing the representativeness of single-center EMR data on ten cancer types: A comparative analysis with national statistics from South Korea (2011–2021)
    Jung-Hyun Won, Howard Lee
    International Journal of Medical Informatics.2026; 214: 106401.     CrossRef
  • Global geographic and socioeconomic disparities in COVID-associated acute kidney injury: a systematic review and meta-analysis
    Danyang Dai, Pedro Franca Gois, Digby Simpson, Souhayel Hedfi, Sally Shrapnel, Jason Donald Pole
    Journal of Global Health.2025;[Epub]     CrossRef
  • Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
    Levente Zsichla, Viktor Müller
    Viruses.2023; 15(1): 175.     CrossRef
  • SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups
    George D Liatsos
    World Journal of Gastroenterology.2023; 29(16): 2397.     CrossRef
  • COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
    Mohammad T. Imam, Ziyad S. Almalki, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, Alaa H. Falemban, Ibrahim M. Alanazi, Naiyer Shahzad, Munira Muhammad Alrooqi, Qaiser Jabeen, Imran Shahid
    International Immunopharmacology.2023; 121: 110439.     CrossRef
  • Clinical Effect of Hepatitis B Virus on COVID-19 Infected Patients: A Nationwide Population-Based Study Using the Health Insurance Review & Assessment Service Database
    Jung Wan Choe, Young Kul Jung, Hyung Joon Yim, Gi Hyeon Seo
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
    Abraham Degarege, Zaeema Naveed, Josiane Kabayundo, David Brett-Major
    Pathogens.2022; 11(5): 563.     CrossRef
  • COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis
    Ramya Nagarajan, Yuvaraj Krishnamoorthy, Sathish Rajaa, Vishnu Shankar Hariharan
    Preventing Chronic Disease.2022;[Epub]     CrossRef
  • Forms of cholangitis to be considered after SARS-CoV-2 infection
    Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
    Clinical and Molecular Hepatology.2022; 28(4): 929.     CrossRef
  • A systems biology approach for investigating significantly expressed genes among COVID-19, hepatocellular carcinoma, and chronic hepatitis B
    Babak Sokouti
    Egyptian Journal of Medical Human Genetics.2022;[Epub]     CrossRef
  • Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
    Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
    Clinical and Molecular Hepatology.2022; 28(4): 926.     CrossRef
  • Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
    Min-Kyu Kang, Yu-Rim Lee, Jeung-Eun Song, Young-Oh Kweon, Won-Young Tak, Se-Young Jang, Jung-Gil Park, Soo-Young Park
    Diagnostics.2022; 12(9): 2255.     CrossRef
  • The association of chronic liver disorders with exacerbation of symptoms and complications related to COVID‐19: A systematic review and meta‐analysis of cohort studies
    Maryam Afraie, Pardis Mohammadzedeh, Mobin Azami, Sorour Khateri, Kamran Zamani, Farhad Moradpour, Yousef Moradi
    The Clinical Respiratory Journal.2022; 16(12): 777.     CrossRef
  • COVID-19 With Preexisting Hypercoagulability Digestive Disease
    Mingshan Jiang, Jingxi Mu, Silan Shen, Hu Zhang
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence
    Jasjit S. Suri, Sushant Agarwal, Suneet K. Gupta, Anudeep Puvvula, Mainak Biswas, Luca Saba, Arindam Bit, Gopal S. Tandel, Mohit Agarwal, Anubhav Patrick, Gavino Faa, Inder M. Singh, Ronald Oberleitner, Monika Turk, Paramjit S. Chadha, Amer M. Johri, J. M
    Computers in Biology and Medicine.2021; 130: 104210.     CrossRef
  • COVID‐19 in hospitalized liver transplant recipients: An early systematic review and meta‐analysis
    Kumar Jayant, Isabella Reccia, Francesco Virdis, Jordan S. Pyda, Piotr J. Bachul, Diego di Sabato, Rolf N. Barth, John Fung, Talia Baker, Piotr Witkowski
    Clinical Transplantation.2021;[Epub]     CrossRef
  • Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic
    Yu Rim Lee
    The Korean Journal of Gastroenterology.2021; 77(4): 156.     CrossRef
  • Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives
    Hung-Yuan Su, Yin-Chou Hsu
    World Journal of Clinical Cases.2021; 9(13): 2951.     CrossRef
  • Italian association for the study of the liver position statement on SARS-CoV2 vaccination
    Francesco Paolo Russo, Salvatore Piano, Raffaele Bruno, Patrizia Burra, Massimo Puoti, Mario Masarone, Sara Montagnese, Francesca Romana Ponziani, Salvatore Petta, Alessio Aghemo
    Digestive and Liver Disease.2021; 53(6): 677.     CrossRef
  • Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
    Wattana Leowattana
    World Journal of Virology.2021; 10(3): 86.     CrossRef
  • Impact of COVID-19 on liver
    Yu-Jang Su, Chen-Wang Chang, Ming-Jen Chen, Yen-Chun Lai
    World Journal of Clinical Cases.2021; 9(27): 7998.     CrossRef
  • Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
    Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
    Clinical and Molecular Hepatology.2021; 27(4): 515.     CrossRef
  • Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies
    Paul Middleton, Catherine Hsu, Mark P Lythgoe
    BMJ Open Gastroenterology.2021; 8(1): e000739.     CrossRef
  • Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment
    Jeong Eun Song, Min Kyu Kang, Yu Rim Lee, Chang Hyeong Lee, Jung Gil Park, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jae Seok Hwang, Byoung Kuk Jang, Won Young Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim
    Gut and Liver.2021; 15(4): 606.     CrossRef
  • Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients
    Cyriac Abby Philips, Mohamed Rela, Arvinder Singh Soin, Subhash Gupta, Sudhindran Surendran, Philip Augustine
    Journal of Clinical and Translational Hepatology.2021; 000(000): 000.     CrossRef
  • 12,542 View
  • 190 Download
  • 24 Web of Science
  • Crossref

Liver fibrosis, cirrhosis, and portal hypertension

Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study
Se Young Jang, Go Heun Kim, Soo Young Park, Chang Min Cho, Won Young Tak, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Jae Myeong Lee, Sang Gyune Kim, Dae Yong Kim, Young Seok Kim, Se-Ok Lee, Yang Won Min, Joon Hyeok Lee, Seung Woon Paik, Byung Chul Yoo, Jae Wan Lim, Hong Joo Kim, Yong Kyun Cho, Joo Hyun Sohn, Jae Yoon Jeong, Yu Hwa Lee, Tae Yeob Kim, Young Oh Kweon
Korean J Hepatol 2012;18(4):368-374.
Published online December 21, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.4.368
Background/Aims

This study evaluated the clinical outcomes of balloon-occluded retrograde transvenous obliteration (BRTO) for the treatment of hemorrhage from gastric varices (GV) in Korean patients with liver cirrhosis (LC).

Methods

We retrospectively analyzed data from 183 LC patients who underwent BRTO for GV bleeding in 6 university-based hospitals between January 2001 and December 2010.

Results

Of the 183 enrolled patients, 49 patients had Child-Pugh (CP) class A LC, 105 had CP class B, and 30 had CP class C at the time of BRTO. BRTO was successfully performed in 177 patients (96.7%). Procedure-related complications (e.g., pulmonary thromboembolism and renal infarction) occurred in eight patients (4.4%). Among 151 patients who underwent follow-up examinations of GV, 79 patients (52.3%) achieved eradication of GV, and 110 patients (72.8%) exhibited marked shrinkage of the treated GV to grade 0 or I. Meanwhile, new-appearance or aggravation of esophageal varices (EV) occurred in 54 out of 136 patients who underwent follow-up endoscopy (41.2%). During the 36.0±29.2 months (mean±SD) of follow-up, 39 patients rebled (hemorrhage from GV in 7, EV in 18, nonvariceal origin in 4, and unknown in 10 patients). The estimated 3-year rebleeding-free rate was 74.8%, and multivariate analysis showed that CP class C was associated with rebleeding (odds ratio, 2.404; 95% confidence-interval, 1.013-5.704; P=0.047).

Conclusions

BRTO can be performed safely and effectively for the treatment of GV bleeding. However, aggravation of EV or bleeding from EV is not uncommon after BRTO; thus, periodic endoscopy to follow-up of EV with or without prophylactic treatment might be necessary in LC patients undergoing BRTO.

Citations

Citations to this article as recorded by  Crossref logo
  • Coil or plug-assisted retrograde transvenous obliteration (CARTO/PARTO) for treating portal hypertensive variceal bleeding: A multicenter, real-world 10-year retrospective study
    Edward Wolfgang Lee, Sammy Saab, Navid Eghbalieh, Peng-Xu Ding, Ung Bae Jeon, Joon Young Ohm, Ronnie C. Chen, Man-Deuk Kim, Kichang Han, Dong Jae Shim, Jong Soo Shin, Anirudh Mirakhur, Chien-An Liu, Jonathan Park, Frank Hao, Man Wong, Antonio Moreno, Jasl
    Hepatology.2025; 82(6): 1498.     CrossRef
  • Prognostic Impact of C-reactive Protein-Albumin-Lymphocyte Index in Patients Who Underwent Splenectomy and Devascularization for Gastric Varices Caused by Portal Hypertension
    Ko Oshita, Tsuyoshi Kobayashi, Naruhiko Honmyo, Seiichi Shimizu, Shintaro Kuroda, Hiroyuki Tahara, Masahiro Ohira, Kentaro Ide, Hideki Ohdan
    Cureus.2025;[Epub]     CrossRef
  • Long-term outcomes of plug-assisted retrograde transvenous obliteration (PARTO) for refractory hepatic encephalopathy
    Dong II Gwon, Gun Ha Kim, Hee Ho Chu, Jihoon Kim, Byoung Soo Im, Eunbyeol Ko, Jeongyeon Kim, Jin Hyoung Kim, Gi-Young Ko, Hyun-Ki Yoon
    European Radiology.2025; 36(1): 719.     CrossRef
  • Clinical Outcomes and Their Determinants in Patients With Gastric Variceal Bleed Undergoing Endoscopic Cyanoacrylate Injection: An Observational Study
    Dharanesh Daneti, Kuppusamy Senthamizhselvan, Mamidala R.V. Chandra, Pazhanivel Mohan, Vikram Kate
    Journal of Clinical and Experimental Hepatology.2024; 14(3): 101315.     CrossRef
  • A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization
    Won‐Mook Choi, Seo Yeon Yoo, Jong‐In Chang, Seungbong Han, Young Seok Kim, Dong Hyun Sinn, Sang Hyun Choi, Dong Il Gwon, Young‐Suk Lim
    Journal of Gastroenterology and Hepatology.2023; 38(9): 1629.     CrossRef
  • Long-Term Prognosis and Related Factors in Patients with Cirrhosis Treated with Balloon-Occluded Retrograde Transvenous Obliteration
    Yamato Tamura, Yoshinari Asaoka, Akihito Takeuchi, Kosuke Matsumoto, Ryo Miura, Koichiro Abe, Toshihiko Arizumi, Masayoshi Yamamoto, Shinya Kodashima, Hiroshi Kondo, Takatsugu Yamamoto, Atsushi Tanaka
    Digestive Diseases.2023; 41(5): 789.     CrossRef
  • Clinical outcomes related to portal pressures before and after embolization of large portosystemic shunts in cirrhosis
    Sasidharan Rajesh, Cyriac Abby Philips, Rizwan Ahamed, Shobhit Singh, Jinsha K Abduljaleel, Ajit Tharakan, Philip Augustine
    SAGE Open Medicine.2023;[Epub]     CrossRef
  • Variceal Hemorrhage: Decompression, Obliteration, or Both?
    Benjamin J. McCafferty, Husamedin El Khudari, Aliaksei Salei, Andrew J. Gunn
    Digestive Disease Interventions.2022; 06(02): 094.     CrossRef
  • Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients
    Taku Mizutani, Kazushige Nirei, Tatsuo Kanda, Masayuki Honda, Tomotaka Ishii, Shuhei Arima, Yoichiro Yamana, Naoki Matsumoto, Shunichi Matsuoka, Mitsuhiko Moriyama
    Medicina.2022; 58(2): 205.     CrossRef
  • Progress in Endoscopic and Interventional Treatment of Esophagogastric Variceal Bleeding
    Bin Liu, Gang Li, Simin Li
    Disease Markers.2022; 2022: 1.     CrossRef
  • Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis
    Han Ah Lee, Jungwon Kwak, Sung Bum Cho, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Seung Up Kim, Hyonggin An, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Comprehensive treatment of patients with gastric variceal bleeding
    S.M. Chooklin, S.S. Chuklin
    EMERGENCY MEDICINE.2022; 18(8): 14.     CrossRef
  • Management of portal hypertension severe complications
    Alberto ZANETTO, Giulio BARBIERO, Michele BATTISTEL, Salvatore S. SCIARRONE, Sarah SHALABY, Monica PELLONE, Sara BATTISTELLA, Martina GAMBATO, Giacomo GERMANI, Francesco P. RUSSO, Patrizia BURRA, Marco SENZOLO
    Minerva Gastroenterology.2021;[Epub]     CrossRef
  • Preloading Coil in Plug Method (p-CIP) with the AVP 2 for large Portosystemic Shunt Embolization
    Kazuki Hashimoto, Yukihisa Ogawa, Shinji Wada, Daichi Kobayashi, Shingo Hamaguchi, Junji Moriya, Hidefumi Mimura
    Radiology Case Reports.2021; 16(10): 2899.     CrossRef
  • Management of portal hypertensive upper gastrointestinal bleeding: Report of the Coorg Consensus workshop of the Indian Society of Gastroenterology Task Force on Upper Gastrointestinal Bleeding
    Shivaram P. Singh, Manav Wadhawan, Subrat K. Acharya, Sawan Bopanna, Kaushal Madan, Manoj K. Sahoo, Naresh Bhat, Sri P. Misra, Ajay Duseja, Amar Mukund, Anil C. Anand, Ashish Goel, Bonthala S. Satyaprakash, Joy Varghese, Manas K. Panigrahi, Manu Tandan, M
    Indian Journal of Gastroenterology.2021; 40(5): 519.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

    Clinical and Molecular Hepatology.2020; 26(2): 83.     CrossRef
  • ACR Appropriateness Criteria® Radiologic Management of Gastric Varices
    Charles Y. Kim, Jason W. Pinchot, Osmanuddin Ahmed, Aaron R. Braun, Brooks D. Cash, Barry W. Feig, Sanjeeva P. Kalva, Erica M. Knavel Koepsel, Matthew J. Scheidt, Kristofer Schramm, David M. Sella, Clifford R. Weiss, Eric J. Hohenwalter
    Journal of the American College of Radiology.2020; 17(5): S239.     CrossRef
  • Managing liver cirrhotic complications: Overview of esophageal and gastric varices
    Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
    Clinical and Molecular Hepatology.2020; 26(4): 444.     CrossRef
  • Change in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous Obliteration
    Jae Woo Park, Jeong-Ju Yoo, Sang Gyune Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Jae Myung Lee, Jong Joon Shim, Young Don Kim, Gab Jin Cheon, Baek Gyu Jun, Young Seok Kim
    Gut and Liver.2020; 14(6): 783.     CrossRef
  • Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis
    Keiji Yokoyama, Ryo Yamauchi, Kumiko Shibata, Hiromi Fukuda, Hideo Kunimoto, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka
    Clinical and Molecular Hepatology.2019; 25(2): 183.     CrossRef
  • Balloon-Assisted Percutaneous Transhepatic Antegrade Embolization with 2-Octyl Cyanoacrylate for the Treatment of Isolated Gastric Varices with Large Gastrorenal Shunts
    Guangchuan Wang, Dongxiao Meng, Guangjun Huang, Qingshan Pei, Lianhui Zhao, Yongjun Shi, Mingyan Zhang, Hua Feng, Junyong Zhang, Chunqing Zhang
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Management Options for Gastric Variceal Hemorrhage
    Edward Wolfgang Lee, Puja Shahrouki, Lourdes Alanis, Pengxu Ding, Stephen T. Kee
    JAMA Surgery.2019; 154(6): 540.     CrossRef
  • Update on management of gastric varices
    Louisa J Vine, Mohsan Subhani, Juan G Acevedo
    World Journal of Hepatology.2019; 11(3): 250.     CrossRef
  • Endoscopic Therapy and Radiologic Intervention of Acute Gastroesophageal Variceal Bleeding
    Jeong Eun Song, Byung Seok Kim
    Clinical Endoscopy.2019; 52(5): 407.     CrossRef
  • Treatment of Gastro-Fundal Varices (Including a Discussion of BRTO)
    Zachary Henry
    Current Hepatology Reports.2018; 17(3): 184.     CrossRef
  • Balloon-Occluded Retrograde Transvenous Obliteration versus Transjugular Intrahepatic Portosystemic Shunt for the Management of Gastric Variceal Bleeding
    Geunwu Gimm, Young Chang, Hyo-Cheol Kim, Aesun Shin, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
    Gut and Liver.2018; 12(6): 704.     CrossRef
  • Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices
    Seung Kwon Kim, Kristen A. Lee, Steven Sauk, Kevin Korenblat
    Korean Journal of Radiology.2017; 18(2): 345.     CrossRef
  • Efficacy of Combined Balloon-occluded Retrograde Transvenous Obliteration and Simultaneous Endoscopic Injection Sclerotherapy
    Wataru Sato, Kentaro Kamada, Takashi Goto, Shigetoshi Ohshima, Kouichi Miura, Tomomi Shibuya, Takahiro Dohmen, Ryo Kanata, Toshitaka Sakai, Mitsuru Chiba, Yuko Sugimoto, Shinichiro Minami, Koichi Ishiyama, Manabu Hashimoto, Hirohide Ohnishi
    Internal Medicine.2015; 54(3): 261.     CrossRef
  • Vascular Plug–Assisted Retrograde Transvenous Obliteration for the Treatment of Gastric Varices and Hepatic Encephalopathy: A Prospective Multicenter Study
    Dong Il Gwon, Young Hwan Kim, Gi-Young Ko, Jong Woo Kim, Heung Kyu Ko, Jin Hyoung Kim, Ji Hoon Shin, Hyun-Ki Yoon, Kyu-Bo Sung
    Journal of Vascular and Interventional Radiology.2015; 26(11): 1589.     CrossRef
  • UK guidelines on the management of variceal haemorrhage in cirrhotic patients
    Dhiraj Tripathi, Adrian J Stanley, Peter C Hayes, David Patch, Charles Millson, Homoyon Mehrzad, Andrew Austin, James W Ferguson, Simon P Olliff, Mark Hudson, John M Christie
    Gut.2015; 64(11): 1680.     CrossRef
  • Endovascular Management of Gastric Varices
    Wael E. Saad
    Clinics in Liver Disease.2014; 18(4): 829.     CrossRef
  • Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results
    Edward W Lee, Sammy Saab, Antoinette S Gomes, Ronald Busuttil, Justin McWilliams, Francisco Durazo, Steven-Huy Han, Leonard Goldstein, Bashir A Tafti, John Moriarty, Christopher T Loh, Stephen T Kee
    Clinical and Translational Gastroenterology.2014; 5(10): e61.     CrossRef
  • Management of Gastric Varices
    Dushant Uppal, Zachary Henry, Abdullah Al-Osaimi, Wael Saad, Stephen Caldwell
    Current Hepatology Reports.2014; 13(3): 208.     CrossRef
  • Treatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder
    Robert Gianotti
    World Journal of Gastroenterology.2014; 20(39): 14495.     CrossRef
  • Update on gastric varices
    Maria Triantafyllou
    World Journal of Gastrointestinal Endoscopy.2014; 6(5): 168.     CrossRef
  • 13,588 View
  • 88 Download
  • Crossref
Case Report
A case of hemocholecyst associated with hemobilia following radiofrequency ablation therapy for hepatocellular carcinoma
Keun Young Shin, Jun Heo, Ji Yeon Kim, Sang Jik Lee, Se Young Jang, Soo Young Park, Min Kyu Jung, Chang Min Cho, Won Young Tak, Young Oh Kweon
Korean J Hepatol 2011;17(2):148-151.
Published online June 23, 2011
DOI: https://doi.org/10.3350/kjhep.2011.17.2.148

Radiofrequency ablation (RFA) is performed as an alternative to surgical resection for primary or secondary liver malignancies. Although RFA can be performed safely in most patients, early and late complications related to mechanical or thermal damage occur in 8-9.5% cases. Hemocholecyst, which refers to hemorrhage of the gallbladder, has been reported with primary gallbladder disease or as a secondary event associated with hemobilia. Hemobilia, defined as hemorrhage in the biliary tract and most commonly associated with accidental or iatrogenic trauma, is a rare complication of RFA. Here we report a case of hemocholecyst associated with hemobilia after RFA for hepatocellular carcinoma that was successfully managed by laparoscopic cholecystectomy.

Citations

Citations to this article as recorded by  Crossref logo
  • Radiofrequency Ablation of Hepatocellular Carcinomas Adjacent to the Gallbladder Without Isolation Under Contrast-Enhanced Ultrasound Monitoring: A Comparative Study with Long Term Follow-Up
    Liping Luo, Ronghua Yan, Qingjing Zeng, Yinglin Long, Xuqi He, Kai Li, Erjiao Xu
    Journal of Hepatocellular Carcinoma.2023; Volume 10: 631.     CrossRef
  • Hemocholecyst caused by accidental injury associated with radiofrequency ablation for hepatocellular carcinoma: A case report
    You-Wen Tan, Xin-Yue Zhang
    World Journal of Clinical Cases.2023; 11(23): 5610.     CrossRef
  • The development of a predictive risk model on post-ablation hemobilia: a multicenter matched case–control study
    Bozhi Liu, Honglu Li, Jiang Guo, Youjia Duan, Changqing Li, Jinglong Chen, Jiasheng Zheng, Wei Li
    The British Journal of Radiology.2021;[Epub]     CrossRef
  • Hemorrhagic cholecystitis: a diagnostic challenge where the radiologist can make the difference
    Giancarlo GISMONDO VELARDI, Angela TETI, Giuseppe E. GRECO, Sandro BALDARI
    Journal of Radiological Review.2021;[Epub]     CrossRef
  • What Is Your Diagnosis?
    Margaux Marclay, Mary Hudson, Rachel A. Jania, Amanda Anderson, L. Abbigail Granger, Rudy Bauer, Andrea N. Johnston
    Journal of the American Veterinary Medical Association.2021; 259(9): 980.     CrossRef
  • Haemocholecyst related to gallbladder malignancy
    Sukanta Ray, Ranajoy Ghosh, Sujan Khamrui, Amit Kumar Das, Suman Saha, Dilip Kumar
    Tropical Doctor.2020; 50(3): 243.     CrossRef
  • Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis
    Masayuki Shishida, Masahiro Ikeda, Nozomi Karakuchi, Kosuke Ono, Naofumi Tsukiyama, Manabu Shimomura, Koichi Oishi, Kazuaki Miyamoto, Kazuhiro Toyota, Seiji Sadamoto, Tadateru Takahashi
    Case Reports in Gastroenterology.2017; 11(2): 488.     CrossRef
  • Treatment of a Hemocholecyst
    Esther Barbon Remis, Aránzazu Martínez Menéndez, Enrique Alexandre Hurle, Jose Manuel Del Casar Lizcano, M. Cruz Díez Santesteban
    Cirugía Española (English Edition).2014; 92(4): 293.     CrossRef
  • Tratamiento laparoscópico de un hemocolecisto
    Esther Barbon Remis, Aránzazu Martínez Menéndez, Enrique Alexandre Hurle, Jose Manuel Del Casar Lizcano, M. Cruz Díez Santesteban
    Cirugía Española.2014; 92(4): 293.     CrossRef
  • Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma
    SY Xu, Y Wang, Q Xie, HY Wu
    Singapore Medical Journal.2013; 54(07): e137.     CrossRef
  • Significance of simultaneous laparoscopic cholecystectomy in thermal ablation for hepatocellular carcinoma located adjacent to gallbladder
    Hiroya Iida, Tsukasa Aihara, Shinichi Ikuta, Hidenori Yoshie, Ryo Okamoto, Naohito Beppu, Munefumi Tomomatsu, Akihiro Maeda, Humihiko Kimura, Masahiro Kishimoto, Hidenori Yanaghi, Ayako Kakuno, Naoki Yamanaka
    Journal of Microwave Surgery.2012; 30: 219.     CrossRef
  • 10,026 View
  • 47 Download
  • Crossref